Skip to main content

Table 2 Demographic data for CSF EV proteomic analysis

From: CSF extracellular vesicle proteomics demonstrates altered protein homeostasis in amyotrophic lateral sclerosis

 

ALS

Healthy control

p

All

C9orf72+

C9orf72

HC vs ALS

C9orf72 + vs non-C9orf72

N

12

3

9

5

%male

66.7

33.3

77.8

20

0.131a

0.236a

Age at sampling, mean ± SD (years)

68.1 ± 12.0

51.9 ± 15.6

65 ± 10.0

52.0 ± 14.8

0.113b

0.166b

Age at onset, mean ± SD (years)

59.7 ± 12.4

51.0 ± 15.6

62.6 ± 10.7

0.229b

% bulbar onset

50.0

66.7

44.4

0.545a

Disease progression rate, median [IQR]

0.53 [0.21–0.63]

0.62 [0.37–0.83]

0.51 [0.22–0.60]

0.782b

  1. ALS amyotrophic lateral sclerosis, HC healthy control, SD standard deviation, IQR interquartile range
  2. aFisher exact test. bKruskal–Wallis H test